chr19-33302091-G-C

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001287424.2(CEBPA):​c.429C>G​(p.Tyr143*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y143Y) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 8.6e-7 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CEBPA
NM_001287424.2 stop_gained

Scores

2
4

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 0.869

Publications

0 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 35 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-33302091-G-C is Pathogenic according to our data. Variant chr19-33302091-G-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 938430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001287424.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
NM_004364.5
MANE Select
c.324C>Gp.Tyr108*
stop_gained
Exon 1 of 1NP_004355.2
CEBPA
NM_001287424.2
c.429C>Gp.Tyr143*
stop_gained
Exon 1 of 1NP_001274353.1
CEBPA
NM_001287435.2
c.282C>Gp.Tyr94*
stop_gained
Exon 1 of 1NP_001274364.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
ENST00000498907.3
TSL:6 MANE Select
c.324C>Gp.Tyr108*
stop_gained
Exon 1 of 1ENSP00000427514.1
CEBPA-DT
ENST00000718467.1
n.46+292G>C
intron
N/A
ENSG00000267727
ENST00000587312.1
TSL:3
n.*151G>C
downstream_gene
N/A

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
8.60e-7
AC:
1
AN:
1162420
Hom.:
0
Cov.:
33
AF XY:
0.00000178
AC XY:
1
AN XY:
562604
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23630
American (AMR)
AF:
0.00
AC:
0
AN:
13484
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17628
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25878
South Asian (SAS)
AF:
0.00
AC:
0
AN:
38122
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3230
European-Non Finnish (NFE)
AF:
0.00000105
AC:
1
AN:
956122
Other (OTH)
AF:
0.00
AC:
0
AN:
45924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Acute myeloid leukemia (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
34
DANN
Uncertain
0.99
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.90
D
PhyloP100
0.87
Vest4
0.63
GERP RS
2.7
PromoterAI
0.012
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555742221; hg19: chr19-33792997; COSMIC: COSV57198636; API